Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    ES11 - Practice Changing Initiatives

    • 09:15 - 10:45
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Nursing and Allied Health Professionals
    • +

      ES11.01 - Chair

      09:15 - 09:15  |  Presenter: Maria Ftanou

      • Abstract

      No abstract available for this presentation

    • +

      ES11.02 - Chair

      09:15 - 09:15  |  Presenter: Anne Fraser

      • Abstract

      No abstract available for this presentation

    • +

      ES11.03 - Managing the Psychological Needs of Patients in a Screening Service

      09:15 - 09:27  |  Presenter: Lisa Burgess

      • Abstract

      Loading...

    • +

      ES11.04 - Assessment of Physical Function in Patients Undergoing Lung-sparing Surgery for Malignant Pleural Mesothelioma

      09:27 - 09:39  |  Presenter: Simon Ho

      • Abstract

      Loading...

    • +

      ES11.05 - Effect of Qigong on Symptom Management of Lung Cancer Patients

      09:39 - 09:51  |  Presenter: Shirley Siu-yin Ching

      • Abstract

      No abstract available for this presentation

    • +

      ES11.06 - Developing a Care Board

      09:51 - 10:03  |  Presenter: Manuela Eicher

      • Abstract

      Loading...

    • +

      ES11.07 - Preoperative Exercise Training for Patients with Non-Small Cell Lung Cancer

      10:03 - 10:18  |  Presenter: Catherine Granger

      • Abstract

      No abstract available for this presentation

    • +

      ES11.08 - Live Q&A

      10:18 - 10:43

      • Abstract

      No abstract available for this presentation

  • +

    ES12 - Public Health Issues in Lung Cancer Screening

    • 10:30 - 11:30
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Screening and Early Detection
    • +

      ES12.01 - Patient Perspective on Lung Cancer Screening and Health Disparities

      10:30 - 10:45  |  Presenter: Andrea Borondy-Kitts

      • Abstract

      Loading...

    • +

      ES12.02 - Defining High Risk

      10:45 - 11:00  |  Presenter: Martin Carl Tammemagi

      • Abstract

      Loading...

    • +

      ES12.03 - Screening in Indigenous Maori Population

      11:00 - 11:15  |  Presenter: Sue Crengle

      • Abstract

      No abstract available for this presentation

    • +

      ES12.04 - Mobile CT and Effective Screening for Underserved Populations

      11:15 - 11:30  |  Presenter: Carlijn van der Aalst

      • Abstract

      No abstract available for this presentation

  • +

    OA07 - Immuno-biology and Novel Immunotherapeutics from Bench to Bed

    • 10:30 - 11:30
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      OA07.01 - Chair

      10:30 - 10:30  |  Presenter: Jyoti D Patel

      • Abstract

      No abstract available for this presentation

    • +

      OA07.02 - Chair

      10:30 - 10:30  |  Presenter: Aaron Lisberg

      • Abstract

      No abstract available for this presentation

    • +

      OA07.03 - Comutations in DDR Pathways Predict Atezolizumab Response in Non-Small Cell Lung Cancer Patients

      10:30 - 10:40  |  Presenter: Wei Nie

      • Abstract

      Loading...

    • +

      OA07.04 - LKB1 Deficiency Leads to an “Adenosine-Rich” Tumor Microenvironment by Recruiting Myeloid-Derived Suppressive Cells

      10:40 - 10:50  |  Presenter: Xue Bai

      • Abstract

      Loading...

    • +

      OA07.05 - Discussant

      10:50 - 10:55  |  Presenter: Myung-Ju Ahn

      • Abstract

      No abstract available for this presentation

    • +

      OA07.06 - Interdependence of KRAS and TP53 Mutations in Predicting ICI Efficacy in EGFR/ALKWT Non-Squamous NSCLC: Results From 1129 Patient-Level Data

      10:55 - 11:00  |  Presenter: Lin Li

      • Abstract

      Loading...

    • +

      OA07.07 - PARP1 Inhibitors Enhanced IFNγ-Induced PD-L1 Expression in LKB1-Mutant Lung Cancer

      11:00 - 11:05  |  Presenter: Xue Bai

      • Abstract

      Loading...

    • +

      OA07.08 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed, Phase II Platform Study in Patients with NSCLC, who Progressed on Anti-PD(L)1 Therapy  

      11:05 - 11:10  |  Presenter: Benjamin Besse

      • Abstract

      Loading...

    • +

      OA07.09 - Sintilimab in Combination with Anlotinib as First-Line Therapy for Advanced NSCLC: Final Analysis of Primary Endpoints

      11:10 - 11:15  |  Presenter: Baohui Han

      • Abstract

      Loading...

    • +

      OA07.10 - Discussant

      11:15 - 11:20  |  Presenter: Laura Mezquita

      • Abstract

      No abstract available for this presentation

    • +

      OA07.11 - Live Q&A

      11:20 - 11:30

      • Abstract

      No abstract available for this presentation

  • +

    ES14 - Novel Immunotherapy Strategies in NSCLC

    • 11:45 - 12:45
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      ES14.02 - Cellular Therapies in NSCLC

      11:45 - 11:57  |  Presenter: Melissa L Johnson

      • Abstract

      Loading...

    • +

      ES14.03 - Combining Epigenetic Therapy and Immunotherapy in NSCLC

      11:57 - 12:09  |  Presenter: Julie Brahmer

      • Abstract

      No abstract available for this presentation

    • +

      ES14.04 - Combining Immunotherapy and Anti-Angiogenic Agents

      12:09 - 12:21  |  Presenter: Enriqueta Felip

      • Abstract

      No abstract available for this presentation

    • +

      ES14.05 - Combining Targeted Therapies With Immunotherapy

      12:21 - 12:33  |  Presenter: Daniel SW Tan

      • Abstract

      No abstract available for this presentation

    • +

      ES14.06 - Novel Immunotherapy Targets in NSCLC

      12:33 - 12:45  |  Presenter: Jie Wang

      • Abstract

      No abstract available for this presentation

  • +

    MA05 - Lung Cancer Screening

    • 11:45 - 12:45
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Screening and Early Detection
    • +

      MA05.01 - Chair

      11:45 - 11:45  |  Presenter: Chong Kin Liam

      • Abstract

      No abstract available for this presentation

    • +

      MA05.02 - Chair

      11:45 - 11:45  |  Presenter: Jacob Sands

      • Abstract

      No abstract available for this presentation

    • +

      MA05.03 - Differential Frequency of Blood Immune Cells as Biomarkers for Risks Assessment in bioMILD Lung Cancer Screening Trial

      11:45 - 11:50  |  Presenter: Gabriella Sozzi

      • Abstract

      Loading...

    • +

      MA05.04 - Why are Lung Cancer Detection Rates Higher in the Manchester Lung Health Checks than in the National Lung Screening Trial?

      11:50 - 11:55  |  Presenter: Hilary A Robbins

      • Abstract

      Loading...

    • +

      MA05.05 - Low-Dose Chest Computed Tomographic Screening and Invasive Diagnosis of Pulmonary Nodules for Lung Cancer in Never-Smokers

      11:55 - 12:00  |  Presenter: Yeon Wook Kim

      • Abstract

      Loading...

    • +

      MA05.06 - Lung Cancer Screening – Cumulative Results from Five UK-Based Programmes

      12:00 - 12:05  |  Presenter: Haval Balata

      • Abstract

      Loading...

    • +

      MA05.07 - Discussant

      12:05 - 12:10  |  Presenter: Stephen Lam

      • Abstract

      No abstract available for this presentation

    • +

      MA05.08 - Impact of Low-Dose CT Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis: Secondary Analysis of NLST

      12:10 - 12:15  |  Presenter: Chloe Chang Su

      • Abstract

      Loading...

    • +

      MA05.09 - Evaluation of Alternative Diagnostic Follow-Up Intervals for Lung-RADs Criteria on the Effectiveness of Lung Cancer Screening 

      12:15 - 12:20  |  Presenter: Mehrad Bastani

      • Abstract

      Loading...

    • +

      MA05.10 - Performance of Draft 2020 USPSTF Lung-Cancer Screening Guidelines and Potential for use of Risk Models to Reduce Racial/Ethnic Disparities

      12:20 - 12:25  |  Presenter: Rebecca Landy

      • Abstract

      Loading...

    • +

      MA05.11 - Effect of Lowering the Starting Age for Lung Cancer Screening by Low-Dose Computed Tomography Among Women: A Harm-Benefit Analysis

      12:25 - 12:30  |  Presenter: Yihui Du

      • Abstract

      Loading...

    • +

      MA05.12 - Discussant

      12:30 - 12:35  |  Presenter: Hui Zhong Chai

      • Abstract

      No abstract available for this presentation

    • +

      MA05.13 - Live Q&A

      12:35 - 12:45

      • Abstract

      No abstract available for this presentation

  • +

    OA08 - Putting the Patient at the Center: Holistic Patient Care

    • 11:45 - 12:45
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Nursing and Allied Health Professionals
    • +

      OA08.01 - Chair

      11:45 - 11:45  |  Presenter: Csaba Laszlo Degi

      • Abstract

      No abstract available for this presentation

    • +

      OA08.02 - Chair

      11:45 - 11:45  |  Presenter: Yeur-Hur Lai

      • Abstract

      No abstract available for this presentation

    • +

      OA08.03 - Joint Modeling of Stress and Survival in Patients with Advanced Non-Small Cell Lung Cancer

      11:45 - 11:55  |  Presenter: Nicole Andrea Arrato

      • Abstract

      Loading...

    • +

      OA08.04 - Providing Thoracic Prehabilitation during COVID-19: Review of a Virtual Model

      11:55 - 12:05  |  Presenter: Stephanie Wynne

      • Abstract

      Loading...

    • +

      OA08.05 - Illness Perception Profiles at Lung Cancer Diagnosis and Physical and Psychological Symptom Trajectories During Treatment

      12:05 - 12:15  |  Presenter: Thomas Robert Valentine

      • Abstract

      Loading...

    • +

      OA08.06 - How Complex is Fatigue? Occupational Therapy Playing a Lead Role in Fatigue Management

      12:15 - 12:25  |  Presenter: Pippa Labuc

      • Abstract

      Loading...

    • +

      OA08.07 - Discussant

      12:25 - 12:35  |  Presenter: Andreas Charalambous

      • Abstract

      No abstract available for this presentation

    • +

      OA08.08 - Live Q&A

      12:35 - 12:45

      • Abstract

      No abstract available for this presentation

  • +

    IS11 - Industry Symposium Sponsored by Amgen Oncology: Advancing the Next Frontier of Innovation in Lung Cancer Therapies

    • 13:00 - 14:00
    • 1/30/2021
    • Location: Industry Symposia Auditorium (via Industry Hub)
    • Not for CME Credit
    • Type: Industry Symposium
    • Track:
    • +

      IS11.01 - Introductions

      13:00 - 13:00

      • Abstract

      No abstract available for this presentation

    • +

      IS11.02 - Current Biomarker Landscape in NSCLC

      13:00 - 13:20  |  Presenter: Stephen Fox

      • Abstract

      No abstract available for this presentation

    • +

      IS11.03 - Current Unmet Need in KRAS G12C-Mutated NSCLC

      13:20 - 13:40  |  Presenter: Koichi Goto

      • Abstract

      No abstract available for this presentation

    • +

      IS11.04 - Emerging Novel Targets for Lung Cancer

      13:40 - 14:00  |  Presenter: Julie Brahmer

      • Abstract

      No abstract available for this presentation

  • +

    IS12 - Industry Symposium Sponsored by: Boehringer Ingelheim: Know Your Patients With NSCLC

    • 13:00 - 14:00
    • 1/30/2021
    • Location: Industry Symposia Auditorium (via Industry Hub)
    • Not for CME Credit
    • Type: Industry Symposium
    • Track:
    • +

      IS12.01 - Introduction

      13:00 - 13:05  |  Presenter: David R. Gandara

      • Abstract

      No abstract available for this presentation

    • +

      IS12.02 - Know How to Test Your Patients

      13:05 - 13:15  |  Presenter: John R Gosney

      • Abstract

      No abstract available for this presentation

    • +

      IS12.03 - Know How to Sequence EGFR TKIS

      13:15 - 13:25  |  Presenter: Barbara Melosky

      • Abstract

      No abstract available for this presentation

    • +

      IS12.04 - Know Your Patients With Uncommon EGFR Mutations

      13:25 - 13:35  |  Presenter: Satoru Miura

      • Abstract

      No abstract available for this presentation

    • +

      IS12.05 - What’s Next for Treatment of Advanced Stage Squamous NSCLC

      13:35 - 13:45  |  Presenter: David R. Gandara

      • Abstract

      No abstract available for this presentation

    • +

      IS12.06 - Know What’s Next for Your Patients: Looking to the Future

      13:45 - 13:55  |  Presenter: David R. Gandara

      • Abstract

      No abstract available for this presentation

    • +

      IS12.07 - Closing

      13:55 - 14:00  |  Presenter: David R. Gandara

      • Abstract

      No abstract available for this presentation

  • +

    IS13 - Satellite CME Symposium by ACE Oncology: Hot Topics in the Management of Advanced Non-Small Cell Lung Cancer: Expert Insights on Recent Advances

    • 13:00 - 14:00
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • CME Accredited by Other Provider
    • Type: Satellite CME Symposia
    • Track:
    • +

      IS13.01 - Welcome, Introduction, and Interactive Quiz

      13:00 - 13:05  |  Presenter: Daniel SW Tan

      • Abstract

      No abstract available for this presentation

    • +

      IS13.02 - When Is the Right Time to Use NGS-Based Liquid Biopsy in Advanced NSCLC?

      13:05 - 13:20  |  Presenter: Herbert H Loong

      • Abstract

      No abstract available for this presentation

    • +

      IS13.03 - Integrating New Targeted Therapy for NSCLC With Rare Oncogenic Drivers Into Clinical Practice

      13:20 - 13:35  |  Presenter: Terufumi Kato

      • Abstract

      No abstract available for this presentation

    • +

      IS13.04 - Enhancing Immune Checkpoint Inhibition With Bifunctional Antibodies

      13:35 - 13:50  |  Presenter: Daniel SW Tan

      • Abstract

      No abstract available for this presentation

    • +

      IS13.05 - Quiz Questions Revisited and Q&A

      13:50 - 13:59

      • Abstract

      No abstract available for this presentation

    • +

      IS13.06 - Pearls for Practice

      13:59 - 14:00  |  Presenter: Daniel SW Tan

      • Abstract

      No abstract available for this presentation

  • +

    ES15 - Getting All NSCLCs Genotyped: How Can We Get to 100%?

    • 14:15 - 15:15
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      ES15.01 - Reflex Genotyping of Advanced NSCLC: The Benefits and the Barriers

      14:15 - 14:30  |  Presenter: Dara Aisner

      • Abstract

      No abstract available for this presentation

    • +

      ES15.02 - Supplementing Tumor Genotyping with ctDNA Genotyping: What Is the Best Approach?

      14:30 - 14:45  |  Presenter: Fernando Lopez-Rios

      • Abstract

      No abstract available for this presentation

    • +

      ES15.04 - Engaging Lung Cancer Patients in their Molecular Testing

      14:45 - 15:00  |  Presenter: Andrew Ciupek

      • Abstract

      Loading...

    • +

      ES15.05 - Effective and Interpretable Reporting of Genotyping Results

      15:00 - 15:15  |  Presenter: Stacy Wang Gray

      • Abstract

      Loading...